review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1440-1746.2000.02260.X |
P698 | PubMed publication ID | 11100988 |
P2093 | author name string | Williams R | |
Riordan SM | |||
P2860 | cites work | Hepatitis G virus infection in fulminant hepatic failure | Q27480284 |
Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria | Q28237954 | ||
Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. | Q44703880 | ||
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases | Q45057671 | ||
Report of new hepatitis virus has researchers intrigued and upset | Q45747706 | ||
Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C. | Q45749810 | ||
Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan | Q45752102 | ||
Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus | Q45764887 | ||
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus | Q45772528 | ||
Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis | Q45784520 | ||
Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation | Q45784836 | ||
Specific histologic features of Santa Marta hepatitis: a severe form of hepatitis delta-virus infection in northern South America | Q45829325 | ||
Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis | Q45852807 | ||
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications | Q45858013 | ||
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure | Q46733753 | ||
Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey | Q46805146 | ||
Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis | Q48277005 | ||
L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. | Q48413744 | ||
Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats | Q48751736 | ||
The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. | Q52243716 | ||
Adult-to-Adult Living Donor Liver Transplantation Using Extended Right Lobe Grafts | Q58236287 | ||
Changing pattern of chronic hepatitis D in Southern Europe | Q58945722 | ||
Early indicators of prognosis in fulminant hepatic failure | Q28241473 | ||
A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology | Q28257014 | ||
Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure | Q28333321 | ||
Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine | Q28334205 | ||
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent | Q29619751 | ||
Principles of therapeutic liver repopulation. | Q33647645 | ||
Hepatocyte transplantation for the treatment of human disease | Q33647660 | ||
Pathophysiology of cerebral edema in fulminant hepatic failure. | Q33768718 | ||
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation | Q34124642 | ||
Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology | Q34288509 | ||
Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure | Q34408649 | ||
Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors | Q34409018 | ||
Epidemiology of hepatitis B virus infection in India | Q34441971 | ||
Epidemiology of hepatitis B infection in the Western Pacific and South East Asia | Q34441984 | ||
Hepatitis B and hepatitis delta virus infection in South America | Q34442036 | ||
Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B. | Q34756315 | ||
HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis | Q36361411 | ||
Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. | Q41145102 | ||
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria | Q42068035 | ||
Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure | Q42285931 | ||
Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction. | Q42978289 | ||
Association between fulminant hepatic failure and a strain of GBV virus C. | Q42980631 | ||
Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome | Q42981633 | ||
GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. | Q42982148 | ||
Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes | Q42982630 | ||
Hepatitis B virus and apparent fulminant non-A, non-B hepatitis | Q42982679 | ||
Genetic evidence for mother-to-infant transmission of hepatitis G virus. | Q42983606 | ||
Diagnosis of type C fulminant hepatitis by the detection of antibodies to the putative core proteins of hepatitis C virus | Q42984207 | ||
Hepatitis C Virus in Fulminant Hepatic Failure | Q42984218 | ||
Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis | Q42984295 | ||
Prevalence, implication, and viral nucleotide sequence analysis of GB virus-C/hepatitis G virus infection in acute fulminant and nonfulminant hepatitis | Q42990097 | ||
Early acquisition of TT virus (TTV) in an area endemic for TTV infection. | Q42992894 | ||
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan | Q42993083 | ||
Detection of hepatitis C and E virus genomes in sera of patients with acute viral hepatitis and fulminant hepatitis by their simultaneous amplification in PCR. | Q42993266 | ||
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology | Q43037556 | ||
Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses | Q43048465 | ||
Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. | Q43048468 | ||
Etiological role of hepatitis E virus in sporadic fulminant hepatitis | Q43049170 | ||
Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study | Q43049617 | ||
Transfusion-associated TT virus infection and its relationship to liver disease | Q43588932 | ||
Fulminant Labrea hepatitis--the role of hepatitis A (HAV), B (HBV), C (HCV), and D (HDV) infection. (Preliminary report) | Q44021126 | ||
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis | Q44367638 | ||
Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial | Q44413698 | ||
P921 | main subject | liver failure | Q970208 |
P304 | page(s) | G17-25 | |
P577 | publication date | 2000-10-01 | |
P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
P1476 | title | Acute liver failure: established and putative hepatitis viruses and therapeutic implications | |
P478 | volume | 15 Suppl |
Q87268823 | APACHE III score is superior to King's College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure |
Q44851733 | Acute liver failure. Current aspects of diagnosis and therapy |
Q42793026 | Liver transplantation for acute hepatic failure |
Q40901952 | Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults |
Q48925185 | Thioacetamide-induced fulminant hepatic failure induces cerebral mitochondrial dysfunction by altering the electron transport chain complexes |
Search more.